Sleep Disorders Trial, Recruiting (NCT07423858)

Sleep Disorders Trial, Recruiting NCT07423858 Sponsor: UMC Utrecht Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT07423858 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 45 years or older who have pain in a hip or knee joint that is related to activity, and whose morning stiffness in that joint lasts no longer than 30 minutes (or no morning stiffness at all), as assessed through a questionnaire based on recognised clinical guidelines for osteoarthritis
People who have had pain in the affected hip or knee joint for at least 3 months
People who have access to a smartphone with an internet connection and an email address
People who are willing and able to give informed consent and to take part in all study assessments and procedures
People who can read and understand Dutch at an everyday, practical level (B1 level)

Who may not be able to join:

People who have a systemic form of arthritis affecting the whole body, such as rheumatoid arthritis or gout
People who are scheduled to have surgery on a hip or knee joint within the next 12 months, or who have had a total hip or total knee replacement in the past 12 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Martijn F. Pisters, PhD, UMC Utrecht

Phone: +31652783039

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07423858

Sponsor: UMC Utrecht

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: +31652783039

More information: https://clinicaltrials.gov/study/NCT07423858

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 45 years or older who have pain in a hip or knee joint that is related to activity, and whose morning stiffness in that joint lasts no longer than 30 minutes (or no morning stiffness at all), as assessed through a questionnaire based on recognised clinical guidelines for osteoarthritis
People who have had pain in the affected hip or knee joint for at least 3 months
People who have access to a smartphone with an internet connection and an email address
People who are willing and able to give informed consent and to take part in all study assessments and procedures
People who can read and understand Dutch at an everyday, practical level (B1 level)

Who may not be able to join:

People who have a systemic form of arthritis affecting the whole body, such as rheumatoid arthritis or gout
People who are scheduled to have surgery on a hip or knee joint within the next 12 months, or who have had a total hip or total knee replacement in the past 12 months

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

UMC Utrecht

Registry

ClinicalTrials.gov

Start date

1 September 2025

Est. completion

1 February 2027

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Physical functioning

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov